Phio Pharmaceuticals to Present at the Life Sciences Future Conference

          Phio Pharmaceuticals to Present at the Life Sciences Future ConferenceKey updates to include advances made in the on-going clinical trial for INTASYL siRNA lead product candidate PH-762September 18, 2025 7:45 AM EDT | Source: Phio Pharmaceuticals Corp.King of Prussia, Pennsylvania--(Newsfile Corp. - September 18, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL® siRNA gene silencing technology  ...